AU618520B2 - Medicaments - Google Patents
Medicaments Download PDFInfo
- Publication number
- AU618520B2 AU618520B2 AU82614/87A AU8261487A AU618520B2 AU 618520 B2 AU618520 B2 AU 618520B2 AU 82614/87 A AU82614/87 A AU 82614/87A AU 8261487 A AU8261487 A AU 8261487A AU 618520 B2 AU618520 B2 AU 618520B2
- Authority
- AU
- Australia
- Prior art keywords
- methyl
- carbazol
- imidazol
- tetrahydro
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8630075 | 1986-12-17 | ||
| GB868630075A GB8630075D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
| GB8726424 | 1987-11-11 | ||
| GB878726424A GB8726424D0 (en) | 1987-11-11 | 1987-11-11 | Medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU8261487A AU8261487A (en) | 1988-06-23 |
| AU618520B2 true AU618520B2 (en) | 1992-01-02 |
Family
ID=26291706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU82614/87A Ceased AU618520B2 (en) | 1986-12-17 | 1987-12-16 | Medicaments |
Country Status (15)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200414A (en) * | 1986-12-17 | 1993-04-06 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
| US5190954A (en) * | 1986-12-17 | 1993-03-02 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
| GB8805269D0 (en) * | 1988-03-04 | 1988-04-07 | Glaxo Group Ltd | Medicaments |
| US5229407A (en) * | 1988-09-01 | 1993-07-20 | Glaxo Group Limited | Medicaments |
| GB8820651D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
| GB8914804D0 (en) * | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
| US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
| EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
| AU2254692A (en) * | 1991-06-26 | 1993-01-25 | Sepracor, Inc. | Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
| JPH06508836A (ja) * | 1991-06-26 | 1994-10-06 | セプラコア，インコーポレーテッド | 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物 |
| JPH08507514A (ja) * | 1993-03-08 | 1996-08-13 | 藤沢薬品工業株式会社 | 脳血管性疾患を治療または予防するための薬物 |
| ZA989365B (en) * | 1997-10-15 | 1999-04-15 | Boehringer Mannheim Pharm Corp | Preparation for treating alzheimer's disease |
| TR200101892T2 (tr) * | 1999-01-07 | 2001-11-21 | P.N. Gerolymatos S.A. | Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı. |
| CA2371822A1 (en) | 1999-03-01 | 2000-09-08 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
| US20020115707A1 (en) * | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
| GB0701970D0 (en) | 2007-02-01 | 2007-03-14 | Wilson Stuart | Treatment of protein aggregation diseases |
| US20100298397A1 (en) * | 2009-05-19 | 2010-11-25 | Singh Nikhilesh N | Method of treatment of obsessive compulsive disorder with ondansetron |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2153821A (en) * | 1984-01-25 | 1985-08-29 | Glaxo Group Ltd | 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives |
| AU583343B2 (en) * | 1985-01-23 | 1989-04-27 | Glaxo Group Limited | Heterocyclic compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI74707C (fi) * | 1982-06-29 | 1988-03-10 | Sandoz Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror. |
| DE3445377A1 (de) * | 1983-12-23 | 1985-07-04 | Sandoz-Patent-GmbH, 7850 Lörrach | Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen |
| US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
| EP0201165B1 (en) * | 1985-03-14 | 1994-07-20 | Beecham Group Plc | Medicaments for the treatment of emesis |
| US4624961A (en) * | 1985-04-17 | 1986-11-25 | A. H. Robins Company, Incorporated | Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes |
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
| HU895334D0 (en) * | 1986-07-30 | 1990-01-28 | Sandoz Ag | Process for the preparation of nasal pharmaceutical compositions |
-
1987
- 1987-12-16 IL IL84845A patent/IL84845A0/xx not_active IP Right Cessation
- 1987-12-16 DK DK662687A patent/DK662687A/da not_active Application Discontinuation
- 1987-12-16 NZ NZ222950A patent/NZ222950A/en unknown
- 1987-12-16 JP JP62318456A patent/JP2608078B2/ja not_active Expired - Lifetime
- 1987-12-16 US US07/133,884 patent/US4845115A/en not_active Expired - Lifetime
- 1987-12-16 DE DE8787311078T patent/DE3782028T2/de not_active Expired - Lifetime
- 1987-12-16 IE IE341487A patent/IE60991B1/en not_active IP Right Cessation
- 1987-12-16 EP EP87311078A patent/EP0275668B1/en not_active Expired - Lifetime
- 1987-12-16 ES ES87311078T patent/ES2052585T3/es not_active Expired - Lifetime
- 1987-12-16 PH PH36242A patent/PH25025A/en unknown
- 1987-12-16 AU AU82614/87A patent/AU618520B2/en not_active Ceased
- 1987-12-17 KR KR1019870014391A patent/KR950013450B1/ko not_active IP Right Cessation
-
1992
- 1992-11-16 GR GR920402595T patent/GR3006255T3/el unknown
-
1993
- 1993-04-15 HK HK366/93A patent/HK36693A/xx not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY169294A patent/CY1692A/xx unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2153821A (en) * | 1984-01-25 | 1985-08-29 | Glaxo Group Ltd | 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives |
| AU583343B2 (en) * | 1985-01-23 | 1989-04-27 | Glaxo Group Limited | Heterocyclic compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2608078B2 (ja) | 1997-05-07 |
| IL84845A0 (en) | 1988-06-30 |
| IE60991B1 (en) | 1994-09-07 |
| KR880007074A (ko) | 1988-08-26 |
| CY1692A (en) | 1994-01-14 |
| ES2052585T3 (es) | 1994-07-16 |
| KR950013450B1 (ko) | 1995-11-08 |
| AU8261487A (en) | 1988-06-23 |
| JPS63253083A (ja) | 1988-10-20 |
| EP0275668A3 (en) | 1989-10-11 |
| DK662687A (da) | 1988-06-18 |
| NZ222950A (en) | 1997-06-24 |
| HK36693A (en) | 1993-04-23 |
| GR3006255T3 (US06566495-20030520-M00011.png) | 1993-06-21 |
| DK662687D0 (da) | 1987-12-16 |
| DE3782028T2 (de) | 1993-02-18 |
| PH25025A (en) | 1991-01-28 |
| US4845115A (en) | 1989-07-04 |
| EP0275668B1 (en) | 1992-09-30 |
| EP0275668A2 (en) | 1988-07-27 |
| IE873414L (en) | 1988-06-17 |
| DE3782028D1 (de) | 1992-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU618520B2 (en) | Medicaments | |
| CA2652662C (en) | Methods for the treatment and prevention of ocular disorders | |
| US5298510A (en) | Medicaments | |
| US4835173A (en) | Method of medical treatment | |
| US5990159A (en) | Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors | |
| EP0615751B1 (en) | Use of tachykinin antagonists in the treatment of emesis | |
| JP2608079B2 (ja) | 医 薬 | |
| US4847281A (en) | Method of medical treatment of addiction | |
| US7713984B2 (en) | Pharmaceutical uses | |
| KR20200077542A (ko) | 지연 방출 데페리프론 정제 및 그의 사용 방법 | |
| JPH0320219A (ja) | 眼内圧降下に有用な選択性α―アドレナリン作働剤および拮抗剤の組み合わせ | |
| TWI833913B (zh) | 含有迪夸弗索(diquafosol)或其鹽、乙烯系高分子及纖維素系高分子之眼科用組合物 | |
| CN110650740A (zh) | 使用ccr3抑制剂治疗视网膜相关疾病的方法和组合物 | |
| JP3541389B2 (ja) | ジヒドロピリジン化合物を含有する眼組織末梢循環改善剤 | |
| AU626010B2 (en) | Medicaments | |
| US5190954A (en) | Methods for the treatment of cognitive disorders | |
| US5198447A (en) | Medicaments | |
| US5200414A (en) | Methods for the treatment of cognitive disorders | |
| TW304879B (US06566495-20030520-M00011.png) | ||
| US20020002179A1 (en) | Terazosin in the chronic treatment of the urinary symptoms associated with benign prostatic hyperplasia | |
| US5244909A (en) | Methods for the treatment of cognitive disorders | |
| JPS63211227A (ja) | 医薬 | |
| WO2011086577A2 (en) | Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts | |
| EP1958949A1 (en) | Therapeutic agent for corneal/conjuctival disease | |
| JPS6254769B2 (US06566495-20030520-M00011.png) |
